255 related articles for article (PubMed ID: 10227815)
41. Sodium aurothiomalate inhibits T cell responses to interleukin-2.
Harth M; Cousin K; McCain GA
Immunopharmacol Immunotoxicol; 1988; 10(2):141-56. PubMed ID: 3139738
[TBL] [Abstract][Full Text] [Related]
42. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
43. Alterations in human monocyte structure and function induced by incubation with gold sodium thiomalate.
Lipsky PE; Ugai K; Ziff M
J Rheumatol Suppl; 1979; 5():130-6. PubMed ID: 114643
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of TPA-induced NF-kappaB nuclear translocation and production of NO and PGE2 by the anti-rheumatic gold compounds.
Yamashita M; Ashino S; Oshima Y; Kawamura S; Ohuchi K; Takayanagi M
J Pharm Pharmacol; 2003 Feb; 55(2):245-51. PubMed ID: 12631417
[TBL] [Abstract][Full Text] [Related]
45. Comparative inhibitory effects of bucillamine and D-penicillamine on the function of human B cells and T cells.
Hirohata S; Lipsky PE
Arthritis Rheum; 1994 Jun; 37(6):942-50. PubMed ID: 8003068
[TBL] [Abstract][Full Text] [Related]
46. Gold sodium thiomalate suppresses the differentiation and function of human dendritic cells from peripheral blood monocytes.
Wang ZY; Morinobu A; Kawano S; Saegusa J; Wang B; Kumagai S
Clin Exp Rheumatol; 2002; 20(5):683-8. PubMed ID: 12412200
[TBL] [Abstract][Full Text] [Related]
47. KE-758, an active metabolite of the new anti-rheumatic drug KE-298, suppresses production of tumor necrosis factor-alpha and interleukin-1 beta in THP-1, a human monocyte cell line.
Sugimoto M; Inoue T; Yamashita M; Takeshita K; Nakaike S
Drugs Exp Clin Res; 2002; 28(5):197-205. PubMed ID: 12635495
[TBL] [Abstract][Full Text] [Related]
48. Effects of gold compounds on leukotriene B4, leukotriene C4 and prostaglandin E2 production by polymorphonuclear leukocytes.
Parente JE; Wong K; Davis P; Burka JF; Percy JS
J Rheumatol; 1986 Feb; 13(1):47-51. PubMed ID: 3009806
[TBL] [Abstract][Full Text] [Related]
49. The modulation of interleukin 1 production by interferon gamma, and the inhibitory effects of gold compounds.
Harth M; McCain GA; Cousin K
Immunopharmacology; 1990; 20(2):125-34. PubMed ID: 2125034
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of expression of cyclin A in human B cells by an immunosuppressant mizoribine.
Hirohata S; Yanagida T
J Immunol; 1995 Dec; 155(11):5175-83. PubMed ID: 7594527
[TBL] [Abstract][Full Text] [Related]
51. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
[TBL] [Abstract][Full Text] [Related]
52. Effect of gold sodium thiomalate on murine lymphocyte functions.
Jennings JJ; Macrae S; Gorczynski RM
Clin Exp Immunol; 1979 May; 36(2):260-5. PubMed ID: 113153
[TBL] [Abstract][Full Text] [Related]
53. Pharmacology of auranofin: overview and update.
Gottlieb NL
Scand J Rheumatol Suppl; 1986; 63():19-28. PubMed ID: 3110942
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of lymphocyte responses by gold: modulation by time of drug addition and antigen dose.
Harth M; Stiller CR
J Rheumatol Suppl; 1979; 5():103-6. PubMed ID: 158653
[TBL] [Abstract][Full Text] [Related]
55. Evidence for immunostimulatory effects of intramuscular gold in patients with rheumatoid arthritis: correlation with skin reactions.
Ernestam S; Lampa J; Rogberg S; Rönnelid J; Klareskog L; Hafström I
J Rheumatol; 2003 Aug; 30(8):1748-55. PubMed ID: 12913930
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of lymphocyte activation by gold sodium thiomalate.
Hopkins SJ; Jayson MI; Van der Zeil P
Br J Pharmacol; 1983 Jun; 79(2):617-22. PubMed ID: 6418247
[TBL] [Abstract][Full Text] [Related]
57. Effects of gold on cytokine production in vitro; increase of monocyte dependent interleukin 10 production and decrease of interferon-gamma levels.
Lampa J; Klareskog L; Rönnelid J
J Rheumatol; 2002 Jan; 29(1):21-8. PubMed ID: 11824965
[TBL] [Abstract][Full Text] [Related]
58. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.
Krampera M; Cosmi L; Angeli R; Pasini A; Liotta F; Andreini A; Santarlasci V; Mazzinghi B; Pizzolo G; Vinante F; Romagnani P; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2006 Feb; 24(2):386-98. PubMed ID: 16123384
[TBL] [Abstract][Full Text] [Related]
59. Bucillamine suppresses human Th1 cell development by a hydrogen peroxide-independent mechanism.
Morinobu A; Wang Z; Kumagai S
J Rheumatol; 2000 Apr; 27(4):851-8. PubMed ID: 10782806
[TBL] [Abstract][Full Text] [Related]
60. The interaction of auranofin and buthionine sulfoximine blocks activation of human peripheral T lymphocytes.
Vint IA; Chain BM; Foreman JC
Cell Immunol; 1993 Nov; 152(1):152-61. PubMed ID: 8242758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
